Coloplast A/S (OTCMKTS:CLPBY) Hits New 52-Week Low – Should You Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $6.50 and last traded at $6.51, with a volume of 7094 shares. The stock had previously closed at $6.56.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CLPBY. Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce”.

Coloplast A/S Trading Down 2.3%

The firm has a market cap of $14.45 billion, a price-to-earnings ratio of 23.74, a price-to-earnings-growth ratio of 0.71 and a beta of 0.50. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. The company has a 50 day moving average price of $7.06 and a 200 day moving average price of $8.21.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings data on Friday, February 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.12 billion. On average, research analysts expect that Coloplast A/S Sponsored ADR will post 0.39 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.